In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Mortality benefit of cardiac rehabilitation after myocardial infarction in the modern era

Session Prognosis and cost-effectiveness of cardiac rehabilitation

Speaker Jacob Klein

Event : ESC Congress 2016

  • Topic : preventive cardiology
  • Sub-topic : Rehabilitation: Outcomes
  • Session type : Moderated Posters

Authors : G Weisz (Jerusalem,IL), N Raviv Abeles (Jerusalem,IL), M Mazar (Jerusalem,IL), A Karawan (Jerusalem,IL), A Kirschner (Jerusalem,IL), Z Mizrachi (Jerusalem,IL), R Aran (Jerusalem,IL), R Farkash (Jerusalem,IL), J Balkin (Jerusalem,IL), M Klutstein (Jerusalem,IL), D Tzivoni (Jerusalem,IL), J Klein (Jerusalem,IL)

Authors:
G. Weisz1 , N. Raviv Abeles1 , M. Mazar1 , A. Karawan1 , A. Kirschner1 , Z. Mizrachi1 , R. Aran1 , R. Farkash1 , J. Balkin1 , M. Klutstein1 , D. Tzivoni1 , J. Klein1 , 1Shaare Zedek Medical Center, Cardiology - Jerusalem - Israel ,

Citation:
European Heart Journal ( 2016 ) 37 ( Abstract Supplement ), 621

Background: Cardiac Rehabilitation (CR) has been shown to be effective in reducing mortality in the era preceding modern treatment of myocardial infarction (MI), but its benefit was questioned following early revascularization. We sought to examine the characteristics and outcomes of MI patients who were eligible and referred for CR.

Methods: Patients with acute MI were referred to an outpatient cardiac Multidisciplinary rehab program. The program included personalized and supervised adjusted physical activity twice weekly for at least 3 months, lifestyle modification interventions, and risk factor control including recommendations for medication adjustments. Patients that could not participate due to orthopedic or cognitive impairments were excluded. We compared the patients who participated in the program to those who were eligible but elected not to participate in the years 2007–2014. Mortality data was extracted from the government civil registry.

Results: Of 4049 eligible patients who were referred to CR, 2079 (51.3%) participated in the program, and 1970 (48.7%) elected not to participate. Independent predictors to participate in the CR program included STEMI, age <75, male gender, non-DM, non-smoker, no prior CABG, and no PVD.

CR as compared to non-CR patients had lower rates of 1-year hospital readmission (11.9% vs. 22.0%, p<0.001), and mortality (0.5% vs. 1.7%, p=0.027). Multivariate analysis revealed that CR was an independent predictor protecting from mortality (OR 0.53, 95% CI 0.44–0.65, p<0.001). Other predictors of mortality included prior CABG (OR 1.53), DM (OR 1.36), and hypertension (OR 1.31), all p<0.01.

Conclusions: Following acute MI, only half of eligible patients who were referred to CR elected to participate. Patients who participated in CR program had a significantly lower readmission rates and lower mortality. Participation in CR rehabilitation program should be vigorously encouraged to all patients after MI.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are